Natural history of HIV-1 infection

被引:67
作者
Vergis, EN
Mellors, JW
机构
[1] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Med Ctr, HIV AIDS Program, Pittsburgh, PA 15213 USA
关键词
D O I
10.1016/S0891-5520(05)70135-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection with the human immunodeficiency virus type 1 (HIV-1) results in progressive loss of immune function marked by depletion of the CD4+ T-lymphocytes, leading to opportunistic infections and malignancies characteristic of AIDS. Although both host and viral determinants influence the rate of disease progression, the median time from initial infection to the development of AIDS among untreated patients ranges from 8 to 10 years. The clinical staging of HIV disease and the relative risk of developing opportunistic infections historically relied on the CD4+ T-lymphocyte counts. Although more recent studies have shown the importance of viral load quantitation in determining the rate of disease progression, it is still useful to categorize HIV disease stage on the basis of the degree of immunodeficiency: early disease (CD4+ > 500 cells/mL), mid-stage disease (CD4+ between 200 and 500 cells/mL), and end-stage disease (CD4+ < 50 cell/ mL). This article reviews the natural history of HIV disease at each stage of HIV-1 infection with emphasis on acute infection and the major virologic and immunologic determinants of disease progression.
引用
收藏
页码:809 / +
页数:19
相关论文
共 124 条
[21]   CHARACTERIZATION OF LYMPHOCYTE-T RESPONSES DURING PRIMARY INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
COOPER, DA ;
TINDALL, B ;
WILSON, EJ ;
IMRIE, AA ;
PENNY, R .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :889-896
[22]  
CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770
[23]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[24]   Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion [J].
Daar, ES ;
Bai, JX ;
Hausner, MA ;
Majchrowicz, M ;
Tamaddon, M ;
Giorgi, JV .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (10) :827-829
[25]  
DAAR ES, 1999, 6 C RETR OPP INF CHI
[26]   Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy [J].
Dalod, M ;
Harzic, M ;
Pellegrin, I ;
Dumon, B ;
Hoen, B ;
Sereni, D ;
Deschemin, JC ;
Levy, JP ;
Venet, A ;
Gomard, E .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :61-69
[27]  
DELRIO C, 1990, REV INFECT DIS, V12, P282
[28]   ACUTE MYELOPATHY ASSOCIATED WITH PRIMARY INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DENNING, DW ;
ANDERSON, J ;
RUDGE, P ;
SMITH, H .
BRITISH MEDICAL JOURNAL, 1987, 294 (6565) :143-144
[29]  
DERONDE A, 1988, LANCET, V2, P574
[30]  
DEWOLF F, 1988, J ROY COLL GEN PRACT, V38, P443